NHS (Neuberger High Yield Strategies Fund Inc.) Stock Analysis - Analyst Ratings

Neuberger High Yield Strategies Fund Inc. (NHS) is a publicly traded Financial Services sector company. As of May 21, 2026, NHS trades at $6.24 with a market cap of $197.31M and a P/E ratio of 0.00. NHS moved +0.56% today. Year to date, NHS is -15.88%; over the trailing twelve months it is -16.56%. Its 52-week range spans $6.13 to $8.67. Rallies surfaces NHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate NHS?

The average price target is $0.00.

NHS Key Metrics

Key financial metrics for NHS
MetricValue
Price$6.24
Market Cap$197.31M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.09%
52-Week High$8.67
52-Week Low$6.13
Volume340.80K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

NHS Analyst Consensus

NHS analyst coverage data. Average price target: $0.00.

Latest NHS News

Recent NHS Insider Trades

  • Kocinski Chris bought 6.00K (~$44.40K) on Jul 17, 2025.
  • Kocinski Chris bought 15.00K (~$111.60K) on May 29, 2025.
  • Lind Joseph bought 5.00K (~$45.71K) on Jun 7, 2022.

Common questions about NHS

What do analysts rate NHS?
The average price target is $0.00.
Does Rallies show NHS price targets?
Yes. Rallies tracks NHS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is NHS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NHS. It does not provide personalized investment advice.
NHS

NHS